Top Genomics And Proteomics Stories


Comment & Analysis »

GBI Research

CRISPR: are genetic mutants the future of disease treatment?

The CRISPR-cas9 system is an up-and-coming biological technique with the potential to revolutionise the medical...

CRISPR: are genetic mutants the future of disease treatment?

Pharma Technology Focus – Issue 50

Pharma Technology Focus – Issue 50
 

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial
 

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

Company Releases »

Critical Containment Products for the Pharmaceutical Industry

PBSC
Critical Containment Products for the Pharmaceutical Industry

Paediatric Clinical Trials 2016

SMI Paediatric Clinical Trials 2016

Genomics And Proteomics Insights »

Companies »